You are here

Position paper - Intellectual property - revised framework for compulsory licensing of patents - call for evidence

uploaded
29 Apr 2022
Healthcare
Intellectual Property

IP plays a key role in advancing scientific research and innovation, and IP rights such as patents permit recuperating investments, provide collaboration between companies and drive efficiency in R&D. In the hopes of tackling fragmentation behind compulsory licenses’ procedures, the EU has opened a consultation for a revised framework for compulsory licensing of patents. Any initiative to improve these frameworks must remain within the parameters of the TRIPS agreement while clearly defining the scope and duration of its application. These and other aspects are key to ensure that the proposal will not affect EU legislation for incentives negatively. Read more about AmCham EU’s position below.